Enzymes participating in tumor metabolism pathway may be interesting drug targets in future chemotherapy; possible drug targets include mitochondrial succinate dehydrogenase (SDH), fumarate hydratase (FH), carnitine palmitoyltransferase (CPT), glycerophosphodiesterase (EDI3) and hypoxia-inducible factors (HIF). This evidence concerns the gene FH and neoplasm.